HIV Lipodystrophy in Participants Randomised to Lopinavir/Ritonavir (LPV/r) +2–3 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) or LPV/r + Raltegravir as Second-Line Antiretroviral Therapy

Hiv Lipodystrophy ◽

Boosted- lopinavir versus boosted- atazanavir plus two nucleoside reverse transcriptase inhibitors in second- line antiretroviral therapy in HIV-1 infected patients in Abidjan (Ivory Coast)

Journal of Microbiology and Infectious Diseases ◽

10.5799/jmid.328859 ◽

2016 ◽

Vol 6 (4) ◽

pp. 149-155

Author(s):

Ehui Eboi

Keyword(s):

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Ivory Coast ◽

Second Line ◽

Nucleoside Reverse Transcriptase Inhibitors ◽

Hiv 1 ◽

Evaluating the Role of Etravirine in the Second-Line Antiretroviral Therapy After Failing an Initial Non-Nucleoside Reverse Transcriptase Inhibitor- Based Regimen in a Resource-Limited Setting§

Current HIV Research ◽

10.2174/157016208785861230 ◽

2008 ◽

Vol 6 (5) ◽

pp. 474-476 ◽

Cited By ~ 13

Author(s):

Somnuek Sungkanuparph ◽

Weerawat Manosuthi ◽

Sasisopin Kiertiburanakul ◽

Bucha Piyavong ◽

Wasun Chantratita

Keyword(s):

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Transcriptase Inhibitor ◽

Second Line ◽

Resource Limited ◽

Reverse Transcriptase Inhibitor ◽

Limited Setting ◽

Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study

The Lancet HIV ◽

10.1016/s2352-3018(16)30189-8 ◽

2017 ◽

Vol 4 (1) ◽

pp. e13-e20 ◽

Cited By ~ 4

Author(s):

Mark A Boyd ◽

Janaki Amin ◽

Patrick W G Mallon ◽

Nagalingeswaran Kumarasamy ◽

Johan Lombaard ◽

...

Keyword(s):

Body Composition ◽

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Virological Failure ◽

Second Line ◽

First Line ◽

Open Label ◽

Therapy Regimen ◽

Metabolic Outcomes

Viral Suppression Following Switch to Second-line Antiretroviral Therapy: Associations With Nucleoside Reverse Transcriptase Inhibitor Resistance and Subtherapeutic Drug Concentrations Prior to Switch

The Journal of Infectious Diseases ◽

10.1093/infdis/jit411 ◽

2013 ◽

Vol 209 (5) ◽

pp. 711-720 ◽

Cited By ~ 36

Author(s):

Victoria Johnston ◽

Karen Cohen ◽

Lubbe Wiesner ◽

Lynn Morris ◽

Johanna Ledwaba ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Nucleoside Reverse Transcriptase Inhibitor ◽

Viral Suppression ◽

Transcriptase Inhibitor ◽

Second Line ◽

Drug Concentrations ◽

Inhibitor Resistance ◽

Reverse Transcriptase Inhibitor ◽

Faculty Opinions recommendation of Lopinavir/ritonavir monotherapy after 24 weeks of second-line antiretroviral therapy in Africa: a randomized controlled trial (SARA).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954092.793459874 ◽

2012 ◽

Author(s):

Joe Eron ◽

Christopher Hurt

Keyword(s):

Randomized Controlled Trial ◽

Antiretroviral Therapy ◽

Controlled Trial ◽

Second Line ◽

Randomized Controlled ◽

Superiority of Protease Inhibitors over Nonnucleoside Reverse-Transcriptase Inhibitors when Highly Active Antiretroviral Therapy Is Resumed after Treatment Interruption

Clinical Infectious Diseases ◽

10.1086/432887 ◽

2005 ◽

Vol 41 (6) ◽

pp. 897-900 ◽

Cited By ~ 8

Author(s):

P. Barreiro ◽

C. de Mendoza ◽

J. Gonzalez-Lahoz ◽

V. Soriano

Keyword(s):

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Protease Inhibitors ◽

Highly Active Antiretroviral Therapy ◽

Treatment Interruption ◽

Nonnucleoside Reverse Transcriptase Inhibitors ◽

Highly Active

Rate of Viral Re-Suppression and Retention to Care Among PLHIV on Second-Line Antiretroviral Therapy at Dessie Comprehensive Specialized Hospital, Northeast Ethiopia: A Retrospective Cohort Study

HIV/AIDS - Research and Palliative Care ◽

10.2147/hiv.s323445 ◽

2021 ◽

Vol Volume 13 ◽

pp. 877-887

Author(s):

Shambel Wedajo ◽

Getu Degu ◽

Amare Deribew ◽

Fentie Ambaw

Keyword(s):

Cohort Study ◽

Antiretroviral Therapy ◽

Retrospective Cohort Study ◽

Retrospective Cohort ◽

Second Line ◽

Northeast Ethiopia ◽

Specialized Hospital ◽

Relationship between untimed plasma lopinavir concentrations and virological outcome on second-line antiretroviral therapy

AIDS ◽

10.1097/qad.0000000000001688 ◽

2018 ◽

Vol 32 (3) ◽

pp. 357-361 ◽

Cited By ~ 1

Author(s):

Gwamaka E. Mwasakifwa ◽

Cecilia Moore ◽

Dianne Carey ◽

Janaki Amin ◽

Paul Penteado ◽

...

Keyword(s):

Antiretroviral Therapy ◽

Second Line ◽

Virological Outcome ◽

Outcomes After Second-Line Antiretroviral Therapy in Children Living with HIV in Latin America

JAIDS Journal of Acquired Immune Deficiency Syndromes ◽

10.1097/qai.0000000000002678 ◽

2021 ◽

Vol Publish Ahead of Print ◽

Author(s):

Kayla Somerville ◽

Cathy A. Jenkins ◽

James G. Carlucci ◽

Anna K. Person ◽

Daisy Maria Machado ◽

...

Keyword(s):

Latin America ◽

Antiretroviral Therapy ◽

Second Line ◽

Living With Hiv ◽

Evaluation of viral resistance to Reverse Transcriptase Inhibitors (RTI) in HIV-1-infected patients before and after 6 months of single or double antiretroviral therapy

The Brazilian Journal of Infectious Diseases ◽

10.1590/s1413-86702001000400003 ◽

2001 ◽

Vol 5 (4) ◽

Cited By ~ 2

Author(s):

Carlos Brites ◽

Fabianna Bahia ◽

Mark Gilbert ◽

Célia Pedroso ◽

Roberto Badaró

Keyword(s):

Antiretroviral Therapy ◽

Reverse Transcriptase ◽

Viral Resistance ◽

Before And After ◽

Hiv 1